OFF LABEL USE | 140 |
DRUG INTERACTION | 112 |
NAUSEA | 65 |
DRUG INEFFECTIVE | 51 |
Product use issue | 47 |
DRUG EXPOSURE DURING PREGNANCY | 45 |
VOMITING | 43 |
FATIGUE | 40 |
HEADACHE | 39 |
PRURITUS | 37 |
DIARRHOEA | 37 |
RASH | 32 |
ABORTION SPONTANEOUS | 31 |
RHABDOMYOLYSIS | 27 |
Product use in unapproved indication | 27 |
THERAPEUTIC RESPONSE UNEXPECTED | 24 |
DIZZINESS | 24 |
Intentional product use issue | 23 |
HEPATOTOXICITY | 23 |
ERYTHEMA | 22 |
ASTHENIA | 22 |
ALANINE AMINOTRANSFERASE INCREASED | 21 |
ADRENAL INSUFFICIENCY | 20 |
JAUNDICE | 19 |
ASPARTATE AMINOTRANSFERASE INCREASED | 19 |
DECREASED APPETITE | 18 |
ABDOMINAL PAIN | 18 |
SKIN EXFOLIATION | 17 |
OVERDOSE | 17 |
HEPATITIS | 17 |
ELECTROCARDIOGRAM QT PROLONGED | 17 |
BURNING SENSATION | 17 |
HEPATIC ENZYME INCREASED | 16 |
NEUTROPENIA | 15 |
DYSPNOEA | 15 |
ALOPECIA | 15 |
RENAL FAILURE ACUTE | 14 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION | 13 |
URTICARIA | 12 |
PAIN | 12 |
HYPOKALAEMIA | 12 |
THROMBOCYTOPENIA | 11 |
PYREXIA | 11 |
HYPOTENSION | 11 |
ECZEMA | 11 |
DEHYDRATION | 11 |
DEATH | 11 |
CONTRAINDICATION TO MEDICAL TREATMENT | 11 |
ANAEMIA | 11 |
ADVERSE EVENT | 11 |
MYALGIA | 10 |
LEUKOPENIA | 10 |
HYPERTENSION | 10 |
DRUG LEVEL INCREASED | 10 |
CONDITION AGGRAVATED | 10 |
CHOLESTASIS | 10 |
TREMOR | 9 |
LIVER FUNCTION TEST ABNORMAL | 9 |
HYPERSENSITIVITY | 9 |
HEPATOCELLULAR INJURY | 9 |
HEPATIC FUNCTION ABNORMAL | 9 |
HEPATIC FAILURE | 9 |
GASTROINTESTINAL DISORDER | 9 |
DRUG-INDUCED LIVER INJURY | 9 |
DRUG HYPERSENSITIVITY | 9 |
Blood creatinine increased | 9 |
ANGIOEDEMA | 9 |
Somnolence | 8 |
RENAL FAILURE | 8 |
PNEUMONIA | 8 |
MUSCULAR WEAKNESS | 8 |
MALAISE | 8 |
HYPERKALAEMIA | 8 |
BLOOD ALKALINE PHOSPHATASE INCREASED | 8 |
WEIGHT DECREASED | 7 |
TRANSAMINASES INCREASED | 7 |
TOXICITY TO VARIOUS AGENTS | 7 |
TOXIC EPIDERMAL NECROLYSIS | 7 |
TINNITUS | 7 |
SKIN BURNING SENSATION | 7 |
PULMONARY EMBOLISM | 7 |
PSORIASIS | 7 |
PANCYTOPENIA | 7 |
Lymphopenia | 7 |
LIVER INJURY | 7 |
LIVER DISORDER | 7 |
HYPOGLYCAEMIA | 7 |
HEPATITIS CHOLESTATIC | 7 |
HEPATIC NECROSIS | 7 |
Hair colour changes | 7 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED | 7 |
FEBRILE NEUTROPENIA | 7 |
ABDOMINAL DISTENSION | 7 |
THERAPEUTIC RESPONSE DECREASED | 6 |
PROSTATE CANCER METASTATIC | 6 |
PARAESTHESIA | 6 |
OEDEMA PERIPHERAL | 6 |
INTERNATIONAL NORMALISED RATIO INCREASED | 6 |
INFECTION | 6 |
HYPOCALCAEMIA | 6 |
FLATULENCE | 6 |
FALL | 6 |
Exposure during pregnancy | 6 |
DRUG INTOLERANCE | 6 |
DISEASE PROGRESSION | 6 |
CONSTIPATION | 6 |
CONFUSIONAL STATE | 6 |
BACK PAIN | 6 |
Application site vesicles | 6 |
ANAPHYLACTIC SHOCK | 6 |
SYNCOPE | 5 |
PRURITUS GENERALISED | 5 |
PROSTATIC SPECIFIC ANTIGEN INCREASED | 5 |
PRODUCT QUALITY ISSUE | 5 |
Papule | 5 |
PAIN IN EXTREMITY | 5 |
OEDEMA | 5 |
MENTAL STATUS CHANGES | 5 |
MALIGNANT NEOPLASM PROGRESSION | 5 |
Hypoalbuminaemia | 5 |
HYPERGLYCAEMIA | 5 |
HEPATITIS ACUTE | 5 |
HAIR TEXTURE ABNORMAL | 5 |
FLUSHING | 5 |
DYSPEPSIA | 5 |
DYSGEUSIA | 5 |
DRY SKIN | 5 |
DRUG DISPENSING ERROR | 5 |
CHROMATURIA | 5 |
BLOOD BILIRUBIN INCREASED | 5 |
ARRHYTHMIA | 5 |
ANAPHYLACTOID REACTION | 5 |
ANAPHYLACTIC REACTION | 5 |
Acute febrile neutrophilic dermatosis | 5 |
Accidental exposure to product | 5 |
ABDOMINAL PAIN UPPER | 5 |
TREATMENT FAILURE | 4 |
SWELLING FACE | 4 |
SWELLING | 4 |
SUICIDAL IDEATION | 4 |
Scab | 4 |
RENAL IMPAIRMENT | 4 |
PUSTULAR PSORIASIS | 4 |
PREMATURE BABY | 4 |
MYOPATHY | 4 |
MUSCLE SPASMS | 4 |
METASTASES TO BONE | 4 |
LOSS OF CONSCIOUSNESS | 4 |
INSOMNIA | 4 |
INCORRECT DOSE ADMINISTERED | 4 |
HYPOPHOSPHATAEMIA | 4 |
HEPATIC CIRRHOSIS | 4 |
GASTROINTESTINAL HAEMORRHAGE | 4 |
EPISTAXIS | 4 |
EOSINOPHILIA | 4 |
DERMATITIS CONTACT | 4 |
CUSHING'S SYNDROME | 4 |
COUGH | 4 |
Contraindicated drug administered | 4 |
Cholestatic liver injury | 4 |
CEREBROVASCULAR ACCIDENT | 4 |
CARDIAC FAILURE CONGESTIVE | 4 |
BLISTER | 4 |
Application site pain | 4 |
Alcohol intolerance | 4 |
ADVERSE DRUG REACTION | 4 |
Abdominal discomfort | 4 |
ABASIA | 4 |
YELLOW SKIN | 3 |
VAGINAL HAEMORRHAGE | 3 |
URINARY RETENTION | 3 |
THERMAL BURN | 3 |
SUDDEN CARDIAC DEATH | 3 |
SKIN DISORDER | 3 |
Sinus congestion | 3 |
SHOCK | 3 |
RASH PRURITIC | 3 |
RASH MACULAR | 3 |
RASH GENERALISED | 3 |
RASH ERYTHEMATOUS | 3 |
Product physical issue | 3 |
PALPITATIONS | 3 |
OCULAR ICTERUS | 3 |
NEUROTOXICITY | 3 |
NEUROPATHY PERIPHERAL | 3 |
NEPHROPATHY TOXIC | 3 |
Multiple chemical sensitivity | 3 |
MUCOSAL INFLAMMATION | 3 |
Mixed liver injury | 3 |
MEDICATION ERROR | 3 |
LUNG INFILTRATION | 3 |
Liver function test increased | 3 |
INCORRECT ROUTE OF DRUG ADMINISTRATION | 3 |
Inappropriate schedule of drug administration | 3 |
Hypothyroidism | 3 |
HYPONATRAEMIA | 3 |
HYPOMAGNESAEMIA | 3 |
HOSPITALISATION | 3 |
Hepatitis toxic | 3 |
HAEMORRHAGE | 3 |
Haemoglobin decreased | 3 |
GENERAL PHYSICAL HEALTH DETERIORATION | 3 |
FUNGAL INFECTION | 3 |
Food allergy | 3 |
FOETAL GROWTH RETARDATION | 3 |
EYELID DISORDER | 3 |
EYE SWELLING | 3 |
DRUG TOXICITY | 3 |
DRUG ERUPTION | 3 |
Disease recurrence | 3 |
DERMATITIS BULLOUS | 3 |
CHILLS | 3 |
BLOOD TESTOSTERONE DECREASED | 3 |
Blood bicarbonate decreased | 3 |
Autoimmune hepatitis | 3 |
ATRIOVENTRICULAR BLOCK COMPLETE | 3 |
ARTHRALGIA | 3 |
Application site swelling | 3 |
Application site pruritus | 3 |
Application site dermatitis | 3 |
ADRENOCORTICAL INSUFFICIENCY ACUTE | 3 |
ACUTE HEPATIC FAILURE | 3 |
Acute generalised exanthematous pustulosis | 3 |
Wrong technique in product usage process | 2 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS | 2 |
Visual impairment | 2 |
VERTIGO | 2 |
VENTRICULAR TACHYCARDIA | 2 |
URINARY TRACT INFECTION | 2 |
Underdose | 2 |
TRISOMY 21 | 2 |
TREATMENT NONCOMPLIANCE | 2 |
TORSADE DE POINTES | 2 |
Therapy non-responder | 2 |
Therapeutic product cross-reactivity | 2 |
STILLBIRTH | 2 |
SKIN ULCER | 2 |
Skin striae | 2 |
SKIN ODOUR ABNORMAL | 2 |
Skin mass | 2 |
Skin fissures | 2 |
SKIN DISCOLOURATION | 2 |
SINUSITIS | 2 |
SEPTIC SHOCK | 2 |
Seizure | 2 |
Seborrhoeic keratosis | 2 |
Seborrhoeic dermatitis | 2 |
RESPIRATORY DISORDER | 2 |
RENAL DISORDER | 2 |
Rash papular | 2 |
PROTHROMBIN TIME PROLONGED | 2 |
PROSTATE CANCER | 2 |
Product physical consistency issue | 2 |
PREMATURE LABOUR | 2 |
Potentiating drug interaction | 2 |
Pleural effusion | 2 |
Platelet count decreased | 2 |
PHARMACEUTICAL PRODUCT COMPLAINT | 2 |
Peripheral swelling | 2 |
PERICARDIAL EFFUSION | 2 |
PAPILLOEDEMA | 2 |
PANCREATITIS | 2 |
Pain of skin | 2 |
OXYGEN SATURATION DECREASED | 2 |
NIGHT SWEATS | 2 |
NEUTROPHIL COUNT DECREASED | 2 |
MYOCARDIAL INFARCTION | 2 |
MULTIPLE CONGENITAL ABNORMALITIES | 2 |
METASTASES TO CENTRAL NERVOUS SYSTEM | 2 |
MEMORY IMPAIRMENT | 2 |
Melanocytic naevus | 2 |
Melaena | 2 |
Macule | 2 |
LYMPHADENOPATHY | 2 |
LIVER TENDERNESS | 2 |
Lipase increased | 2 |
Lip swelling | 2 |
LETHARGY | 2 |
KERATOPATHY | 2 |
INFLAMMATION | 2 |
Illness | 2 |
HYPOXIA | 2 |
HYPOGLYCAEMIA NEONATAL | 2 |
HYPOAESTHESIA | 2 |
Hypertriglyceridaemia | 2 |
Hypercalcaemia | 2 |
Hyperbilirubinaemia | 2 |
HEPATITIS FULMINANT | 2 |
HEPATIC STEATOSIS | 2 |
HEPATIC PAIN | 2 |
HEART RATE INCREASED | 2 |
GENERALISED OEDEMA | 2 |
GENERALISED ERYTHEMA | 2 |
GASTRITIS | 2 |
GAIT DISTURBANCE | 2 |
Eye pain | 2 |
EYE IRRITATION | 2 |
ERYTHEMA NODOSUM | 2 |
Erectile dysfunction | 2 |
Embolism | 2 |
ELECTROLYTE IMBALANCE | 2 |
EATING DISORDER | 2 |
DYSPNOEA EXERTIONAL | 2 |
DYSMORPHISM | 2 |
Dysmenorrhoea | 2 |
Dyslipidaemia | 2 |
DRY EYE | 2 |
Drug resistance | 2 |
Drug reaction with eosinophilia and systemic symptoms | 2 |
Drug prescribing error | 2 |
Drug effect incomplete | 2 |
DRUG ADMINISTRATION ERROR | 2 |
Drug administered at inappropriate site | 2 |
DISSEMINATED INTRAVASCULAR COAGULATION | 2 |
DERMATITIS EXFOLIATIVE | 2 |
Dermatitis | 2 |
Depression | 2 |
Dental caries | 2 |
CYTOLYTIC HEPATITIS | 2 |
CYTOGENETIC ABNORMALITY | 2 |
CYANOSIS | 2 |
Cortisol increased | 2 |
CORTISOL FREE URINE DECREASED | 2 |
CONVULSION | 2 |
CONJUNCTIVITIS | 2 |
CONGENITAL FOOT MALFORMATION | 2 |
CONGENITAL ANOMALY | 2 |
COAGULOPATHY | 2 |
CLEFT LIP | 2 |
Chest pain | 2 |
Chemical burn of skin | 2 |
Chemical burn | 2 |
CHAPPED LIPS | 2 |
CELLULITIS | 2 |
CARDIO-RESPIRATORY ARREST | 2 |
Cardiac arrest | 2 |
BRONCHOSPASM | 2 |
BLOOD CREATINE PHOSPHOKINASE INCREASED | 2 |
BLOOD CORTICOTROPHIN INCREASED | 2 |
BLOOD ALKALINE PHOSPHATASE ABNORMAL | 2 |
BLIGHTED OVUM | 2 |
BACTERIAL INFECTION | 2 |
ATRIOVENTRICULAR BLOCK | 2 |
ASTHMA | 2 |
Arthropod bite | 2 |
Application site erythema | 2 |
AGGRESSION | 2 |
Acute kidney injury | 2 |
ACCIDENTAL EXPOSURE | 2 |
Wrong product administered | 1 |
WOUND | 1 |
Withdrawal syndrome | 1 |
White blood cell count decreased | 1 |
Weight increased | 1 |
VIth nerve paralysis | 1 |
Visual field defect | 1 |
VISUAL ACUITY REDUCED | 1 |
VISION BLURRED | 1 |
Ventricular extrasystoles | 1 |
VENTRICULAR ARRHYTHMIA | 1 |
Vasodilation procedure | 1 |
Vasodilatation | 1 |
Vasculitis | 1 |
VAGINAL ODOUR | 1 |
VAGINAL DISCHARGE | 1 |
UTERINE HAEMORRHAGE | 1 |
UROSEPSIS | 1 |
Urine output decreased | 1 |
URINE ANALYSIS ABNORMAL | 1 |
URINARY TRACT INFECTION ENTEROCOCCAL | 1 |
Urinary incontinence | 1 |
ULCERATIVE KERATITIS | 1 |
ULCER | 1 |
TYPE IV HYPERSENSITIVITY REACTION | 1 |
Type I hypersensitivity | 1 |
Transplant rejection | 1 |
Transcription medication error | 1 |
TOXIC SKIN ERUPTION | 1 |
Tinea pedis | 1 |
Tinea infection | 1 |
Thyroid cancer | 1 |
THROAT IRRITATION | 1 |
Therapeutic response delayed | 1 |
Therapeutic product effect decreased | 1 |
TENDONITIS | 1 |
TEARFULNESS | 1 |
Taste disorder | 1 |
Tachycardia | 1 |
Surgical failure | 1 |
Superinfection | 1 |
Superficial inflammatory dermatosis | 1 |
Subileus | 1 |
SUBCUTANEOUS HAEMATOMA | 1 |
Subcutaneous abscess | 1 |
SUBACUTE HEPATIC FAILURE | 1 |
Stress | 1 |
Staphylococcal infection | 1 |
Staphylococcal bacteraemia | 1 |
SPINAL CORD NEOPLASM | 1 |
SPINAL CORD INJURY | 1 |
SPINAL CORD COMPRESSION | 1 |
Skin warm | 1 |
Skin reaction | 1 |
SKIN NODULE | 1 |
Skin lesion | 1 |
SKIN HYPOPIGMENTATION | 1 |
Skin hyperpigmentation | 1 |
SKIN HAEMORRHAGE | 1 |
Sinus bradycardia | 1 |
Sickle cell anaemia with crisis | 1 |
SEPSIS | 1 |
Sensory loss | 1 |
Self injurious behaviour | 1 |
SEBORRHOEA | 1 |
Scar | 1 |
Rhinorrhoea | 1 |
RETROPERITONEAL FIBROSIS | 1 |
RETROGNATHIA | 1 |
RESUSCITATION | 1 |
Respiratory rate decreased | 1 |
RESPIRATORY FAILURE | 1 |
Respiratory distress | 1 |
Renal tubular necrosis | 1 |
Renal failure chronic | 1 |
REGURGITATION | 1 |
Refusal of treatment by patient | 1 |
Red cell distribution width abnormal | 1 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED | 1 |
RED BLOOD CELL COUNT INCREASED | 1 |
Red blood cell abnormality | 1 |
RECTAL HAEMORRHAGE | 1 |
Rash maculo-papular | 1 |
Radial nerve palsy | 1 |
Purulent discharge | 1 |
Pulmonary oedema | 1 |
Pulmonary nocardiosis | 1 |
Psychotic disorder | 1 |
PSEUDOBULBAR PALSY | 1 |
Prurigo | 1 |
Proteinuria | 1 |
PROSTATIC SPECIFIC ANTIGEN DECREASED | 1 |
PROSTATE CANCER RECURRENT | 1 |
PROLACTINOMA | 1 |
Product residue present | 1 |
Product packaging issue | 1 |
Product odour abnormal | 1 |
Product label issue | 1 |
Product formulation issue | 1 |
Product dose omission issue | 1 |
Product dispensing issue | 1 |
Product counterfeit | 1 |
Product container seal issue | 1 |
Product container issue | 1 |
Product colour issue | 1 |
Priapism | 1 |
Premature separation of placenta | 1 |
PREGNANCY INDUCED HYPERTENSION | 1 |
Post procedural complication | 1 |
PORTAL HYPERTENSION | 1 |
POLYURIA | 1 |
POLYDIPSIA | 1 |
Poisoning deliberate | 1 |
Pneumothorax | 1 |
Pneumocystis jirovecii pneumonia | 1 |
PNEUMOCYSTIS JIROVECI PNEUMONIA | 1 |
Platelet distribution width abnormal | 1 |
PLACENTAL DISORDER | 1 |
PITYRIASIS RUBRA PILARIS | 1 |
Pituitary tumour benign | 1 |
Pigmentation disorder | 1 |
Photosensitivity reaction | 1 |
Photophobia | 1 |
Pharyngeal oedema | 1 |
PERITONITIS BACTERIAL | 1 |
Peripheral sensory neuropathy | 1 |
PERIPHERAL COLDNESS | 1 |
Peripheral artery occlusion | 1 |
PERIORBITAL CELLULITIS | 1 |
Performance status decreased | 1 |
Pancreatic neuroendocrine tumour metastatic | 1 |
PANCREATIC DISORDER | 1 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME | 1 |
Pallor | 1 |
Painful erection | 1 |
OSTEOPOROSIS | 1 |
Osteomyelitis | 1 |
Oral pain | 1 |
ORAL INTAKE REDUCED | 1 |
ORAL CANDIDIASIS | 1 |
Onychomycosis | 1 |
OLIGURIA | 1 |
Ocular hyperaemia | 1 |
Nocardiosis | 1 |
No therapeutic response | 1 |
No adverse event | 1 |
NO ADVERSE DRUG EFFECT | 1 |
NIPPLE DISORDER | 1 |
Neutrophil percentage abnormal | 1 |
NEUTROPHIL COUNT INCREASED | 1 |
Neutrophil count abnormal | 1 |
Neutropenic sepsis | 1 |
Nervous system disorder | 1 |
Neoplasm skin | 1 |
Neoplasm progression | 1 |
NEOPLASM | 1 |
Neck pain | 1 |
Nasopharyngitis | 1 |
Nail disorder | 1 |
MYOSITIS | 1 |
MYOCLONUS | 1 |
Mycosis fungoides | 1 |
Musculoskeletal stiffness | 1 |
MUSCULOSKELETAL PAIN | 1 |
Multi-organ failure | 1 |
MOVEMENT DISORDER | 1 |
MOOD ALTERED | 1 |
Monocyte percentage abnormal | 1 |
Monocyte count abnormal | 1 |
Migraine | 1 |
Micturition urgency | 1 |
MICTURITION DISORDER | 1 |
MICROGNATHIA | 1 |
METASTATIC PAIN | 1 |
METASTATIC NEOPLASM | 1 |
Metastases to liver | 1 |
Metabolic disorder | 1 |
Menstrual disorder | 1 |
Mean cell volume abnormal | 1 |
MATERNAL DRUGS AFFECTING FOETUS | 1 |
Mass | 1 |
Mania | 1 |
MALIGNANT PLEURAL EFFUSION | 1 |
MALIGNANT HYPERTENSION | 1 |
Lymphocyte percentage abnormal | 1 |
LUNG NEOPLASM MALIGNANT | 1 |
Lung infection | 1 |
LUNG DISORDER | 1 |
Lung consolidation | 1 |
LOW SET EARS | 1 |
Loss of libido | 1 |
Localised oedema | 1 |
Local reaction | 1 |
LIVER TRANSPLANT | 1 |
Livedo reticularis | 1 |
Lip dry | 1 |
LIMB REDUCTION DEFECT | 1 |
LIMB MALFORMATION | 1 |
LICHENOID KERATOSIS | 1 |
LEUKODERMA | 1 |
Leukocytosis | 1 |
Leukocytoclastic vasculitis | 1 |
Lentigo | 1 |
Lacrimation increased | 1 |
Laceration | 1 |
Labelled drug-drug interaction medication error | 1 |
KLEBSIELLA INFECTION | 1 |
KERATITIS | 1 |
JOINT ANKYLOSIS | 1 |
ISCHAEMIC STROKE | 1 |
INTRACRANIAL PRESSURE INCREASED | 1 |
INTRA-UTERINE DEATH | 1 |
INTERSTITIAL LUNG DISEASE | 1 |
Intercepted product administration error | 1 |
Intentional product misuse | 1 |
INTENTIONAL DRUG MISUSE | 1 |
Injury | 1 |
INJECTION SITE IRRITATION | 1 |
INJECTION SITE ERYTHEMA | 1 |
INFLUENZA LIKE ILLNESS | 1 |
Incorrect route of product administration | 1 |
Inappropriate schedule of product administration | 1 |
IMPAIRED GASTRIC EMPTYING | 1 |
Immunosuppressant drug level decreased | 1 |
ILEUS | 1 |
IDIOSYNCRATIC DRUG REACTION | 1 |
Idiopathic intracranial hypertension | 1 |
Idiopathic guttate hypomelanosis | 1 |
HYPOVOLAEMIC SHOCK | 1 |
HYPOVOLAEMIA | 1 |
Hypothalamic pituitary adrenal axis suppression | 1 |
HYPOPLASTIC LEFT HEART SYNDROME | 1 |
HYPOPITUITARISM | 1 |
Hypokinesia | 1 |
Hypoacusis | 1 |
Hypervolaemia | 1 |
Hypertonia | 1 |
Hyperthermia | 1 |
Hypertensive crisis | 1 |
Hyperpyrexia | 1 |
Hyperhidrosis | 1 |
HYPERCHOLESTEROLAEMIA | 1 |
Hyperadrenocorticism | 1 |
Hot flush | 1 |
Hormone-refractory prostate cancer | 1 |
HISTOPLASMOSIS | 1 |
Hirsutism | 1 |
HIP FRACTURE | 1 |
High density lipoprotein abnormal | 1 |
HIGH ARCHED PALATE | 1 |
Hidradenitis | 1 |
HERPES ZOSTER | 1 |
HERPES VIRUS INFECTION | 1 |
Hepatosplenomegaly | 1 |
HEPATITIS VIRAL | 1 |
HEPATIC ENCEPHALOPATHY | 1 |
HEPATIC CYST | 1 |
HELLP SYNDROME | 1 |
Helicobacter infection | 1 |
Hearing impaired | 1 |
Hair injury | 1 |
Hair disorder | 1 |
Haemorrhage subcutaneous | 1 |
HAEMORRHAGE INTRACRANIAL | 1 |
HAEMODIALYSIS | 1 |
Haematuria | 1 |
Haematochezia | 1 |
Haemangioma of skin | 1 |
Haemangioma | 1 |
Gynaecomastia | 1 |
Groin pain | 1 |
Genital swelling | 1 |
GENITAL BURNING SENSATION | 1 |
Gastric disorder | 1 |
Gastric cancer stage IV | 1 |
Furuncle | 1 |
Folliculitis | 1 |
Foetal exposure during pregnancy | 1 |
Foaming at mouth | 1 |
Fixed eruption | 1 |
Fistula | 1 |
FEMUR FRACTURE | 1 |
Feeling jittery | 1 |
FEELING HOT | 1 |
FEELING DRUNK | 1 |
Feeling cold | 1 |
FAMILY STRESS | 1 |
FAECES DISCOLOURED | 1 |
FAECALOMA | 1 |
FACE OEDEMA | 1 |
Eyelid pain | 1 |
Eyelid margin crusting | 1 |
EYE BURNS | 1 |
Expired product administered | 1 |
Euphoric mood | 1 |
Escherichia urinary tract infection | 1 |
ESCHERICHIA SEPSIS | 1 |
EPILEPSY | 1 |
Ephelides | 1 |
EOSINOPHIL COUNT INCREASED | 1 |
Encephalitis fungal | 1 |
EJECTION FRACTION DECREASED | 1 |
Educational problem | 1 |
ECTOPIC PREGNANCY | 1 |
Dysuria | 1 |
Dysphagia | 1 |
DYSHIDROSIS | 1 |
DYSARTHRIA | 1 |
DRY MOUTH | 1 |
Drug tolerance decreased | 1 |
Drug level below therapeutic | 1 |
Drug level above therapeutic | 1 |
Drug effective for unapproved indication | 1 |
Drug dose omission | 1 |
DRUG ABUSE | 1 |
DISTURBANCE IN SOCIAL BEHAVIOUR | 1 |
Discomfort | 1 |
DIALYSIS | 1 |
DIABETES MELLITUS | 1 |
DIABETES INSIPIDUS | 1 |
DEVELOPMENTAL DELAY | 1 |
Dermatitis atopic | 1 |
DEPRESSED MOOD | 1 |
Deep vein thrombosis | 1 |
DEAFNESS TRANSITORY | 1 |
CYTOMEGALOVIRUS INFECTION | 1 |
CRYPTORCHISM | 1 |
Crying | 1 |
Creatinine renal clearance decreased | 1 |
Cortisol free urine increased | 1 |
CORNEAL SCAR | 1 |
CORNEAL REFLEX DECREASED | 1 |
CORNEAL OPACITY | 1 |
CORNEAL EROSION | 1 |
Contusion | 1 |
Contraindicated product administered | 1 |
Conjunctival irritation | 1 |
CONJUNCTIVAL DISORDER | 1 |
CONGENITAL HAND MALFORMATION | 1 |
CONGENITAL GASTRIC ANOMALY | 1 |
CONGENITAL EYE DISORDER | 1 |
COMPLETED SUICIDE | 1 |
COMA HEPATIC | 1 |
Colour vision tests normal | 1 |
COLON CANCER | 1 |
COLITIS ISCHAEMIC | 1 |
COAGULATION TIME PROLONGED | 1 |
CLINODACTYLY | 1 |
Cholecystitis acute | 1 |
CHOLECYSTITIS | 1 |
Choking sensation | 1 |
CHEST X-RAY ABNORMAL | 1 |
Chest discomfort | 1 |
Change of bowel habit | 1 |
Central vision loss | 1 |
CAROTID ARTERY STENOSIS | 1 |
Cardiovascular disorder | 1 |
CARDIOTOXICITY | 1 |
CARDIAC FIBRILLATION | 1 |
CARDIAC FAILURE | 1 |
Bundle branch block | 1 |
BRAIN NEOPLASM | 1 |
Bradycardia | 1 |
BONE SWELLING | 1 |
BONE MARROW FAILURE | 1 |
Blood urea increased | 1 |
Blood triglycerides increased | 1 |
Blood testosterone increased | 1 |
Blood testosterone abnormal | 1 |
Blood pressure increased | 1 |
BLOOD PRESSURE DECREASED | 1 |
Blood lactate dehydrogenase abnormal | 1 |
BLOOD LACTATE DEHYDROGENASE | 1 |
Blood insulin decreased | 1 |
BLOOD IMMUNOGLOBULIN M INCREASED | 1 |
Blood glucose increased | 1 |
Blood glucose fluctuation | 1 |
Blood cortisol increased | 1 |
Blood cortisol decreased | 1 |
Blood cholesterol increased | 1 |
Blood calcium increased | 1 |
BLOOD CALCIUM DECREASED | 1 |
Blindness unilateral | 1 |
Blepharitis allergic | 1 |
Bladder dilatation | 1 |
BIOPSY BONE MARROW ABNORMAL | 1 |
BILIRUBIN CONJUGATED INCREASED | 1 |
BILE DUCT STONE | 1 |
BENIGN INTRACRANIAL HYPERTENSION | 1 |
BENIGN CONGENITAL HYPOTONIA | 1 |
BEDRIDDEN | 1 |
Basal ganglia haemorrhage | 1 |
AURICULAR SWELLING | 1 |
ATYPICAL MYCOBACTERIUM TEST POSITIVE | 1 |
Atrioventricular block first degree | 1 |
Atrial fibrillation | 1 |
Asphyxia | 1 |
ASCITES | 1 |
Arrhythmia supraventricular | 1 |
APPLICATION SITE REACTION | 1 |
Application site rash | 1 |
APPLICATION SITE PHOTOSENSITIVITY REACTION | 1 |
Application site irritation | 1 |
Application site hypersensitivity | 1 |
APPLICATION SITE EXCORIATION | 1 |
APPLICATION SITE DISCHARGE | 1 |
Apparent mineralocorticoid excess | 1 |
APLASTIC ANAEMIA | 1 |
Aphagia | 1 |
ANOREXIA | 1 |
ANOMALY OF EXTERNAL EAR CONGENITAL | 1 |
ANGIONEUROTIC OEDEMA | 1 |
Amylase increased | 1 |
AMNESTIC DISORDER | 1 |
Allergic reaction to excipient | 1 |
ALKALOSIS HYPOCHLORAEMIC | 1 |
ALCOHOL USE | 1 |
AGRANULOCYTOSIS | 1 |
ADRENAL MASS | 1 |
ADRENAL DISORDER | 1 |
Adenoma benign | 1 |
Acute respiratory failure | 1 |
Acute coronary syndrome | 1 |
ACTIVITIES OF DAILY LIVING IMPAIRED | 1 |
Actinic keratosis | 1 |
ACNE PUSTULAR | 1 |
Acne | 1 |
ACIDOSIS | 1 |
Accidental overdose | 1 |
Accidental exposure to product by child | 1 |
ACCESSORY AURICLE | 1 |
ABORTION MISSED | 1 |
ABORTION INDUCED | 1 |
ABORTION INCOMPLETE | 1 |
ABNORMAL SENSATION IN EYE | 1 |
ABNORMAL PALMAR/PLANTAR CREASES | 1 |
Abdominal symptom | 1 |
Abdominal pain lower | 1 |